Bandaram Pharma Board Meeting on Aug 13 to Review Q1 FY27 Results

Bandaram Pharma Packtech Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the board will discuss any other business with the Chair's permission. The company has also informed that the trading window for dealing in its securities is closed from July 1, 2026, until 48 hours after the declaration of these financial results, in compliance with SEBI regulations.